Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas

BACKGROUND: Chemotherapy resistance remains a major obstacle in the treatment of women with ovarian cancer. Establishing predictive markers of chemoresponse would help to individualize therapy and improve survival of ovarian cancer patients. Chemotherapy resistance in ovarian cancer has been studied...

Descripción completa

Detalles Bibliográficos
Autores principales: Österberg, Lovisa, Levan, Kristina, Partheen, Karolina, Delle, Ulla, Olsson, Björn, Sundfeldt, Karin, Horvath, György
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770569/
https://www.ncbi.nlm.nih.gov/pubmed/19835627
http://dx.doi.org/10.1186/1471-2407-9-368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770569/
https://www.ncbi.nlm.nih.gov/pubmed/19835627
http://dx.doi.org/10.1186/1471-2407-9-368

Ejemplares similares